Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Signatures of cardioembolic and large-vessel ischemic stroke.

Jickling GC, Xu H, Stamova B, Ander BP, Zhan X, Tian Y, Liu D, Turner RJ, Mesias M, Verro P, Khoury J, Jauch EC, Pancioli A, Broderick JP, Sharp FR.

Ann Neurol. 2010 Nov;68(5):681-92. doi: 10.1002/ana.22187.

2.

Cardioembolic stroke diagnosis using blood biomarkers.

Llombart V, Garcia-Berrocoso T, Bustamante A, Fernandez-Cadenas I, Montaner J.

Curr Cardiol Rev. 2013 Nov;9(4):340-52. Review.

3.

Identification of Covert Atrial Fibrillation in Cryptogenic Ischemic Stroke: Current Clinical Practice in Japan.

Toyoda K, Okumura K, Hashimoto Y, Ikeda T, Komatsu T, Hirano T, Fukuda H, Matsumoto K, Yasaka M.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1829-37. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.012. Epub 2016 Jun 6. Review.

PMID:
27282299
4.

[Prevention of cardioembolic stroke].

Gil Núñez A.

Neurologia. 2012 Mar;27 Suppl 1:15-26. doi: 10.1016/S0213-4853(12)70004-X. Review. Spanish.

5.

Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans.

Sharp FR, Jickling GC, Stamova B, Tian Y, Zhan X, Liu D, Kuczynski B, Cox CD, Ander BP.

J Cereb Blood Flow Metab. 2011 Jul;31(7):1513-31. doi: 10.1038/jcbfm.2011.45. Epub 2011 Apr 20. Review.

6.

Atrial Septal Defects and Cardioembolic Strokes.

Leppert M, Poisson SN, Carroll JD.

Cardiol Clin. 2016 May;34(2):225-30. doi: 10.1016/j.ccl.2015.12.004. Epub 2016 Mar 9. Review.

PMID:
27150170
7.

Atrial fibrillation and cardioembolic stroke.

Ferro JM.

Minerva Cardioangiol. 2004 Apr;52(2):111-24. Review.

8.

Stroke prevention in atrial fibrillation and other major cardiac sources of embolism.

Freeman WD, Aguilar MI.

Neurol Clin. 2008 Nov;26(4):1129-60, x-xi. doi: 10.1016/j.ncl.2008.07.001. Review.

PMID:
19026905
9.

B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis.

Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodríguez-Yáñez M, Fonseca AC, Watanabe T, Purroy F, Zhixin W, Etgen T, Hosomi N, Jafarian Kerman SR, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, García-Berrocoso T, Montaner J.

Stroke. 2015 May;46(5):1187-95. doi: 10.1161/STROKEAHA.114.008311. Epub 2015 Mar 12. Review.

10.

Blood biomarkers of ischemic stroke.

Jickling GC, Sharp FR.

Neurotherapeutics. 2011 Jul;8(3):349-60. doi: 10.1007/s13311-011-0050-4. Review.

11.

Blood markers of inflammation and endothelial dysfunction in cardioembolic stroke: systematic review and meta-analysis.

Piccardi B, Giralt D, Bustamante A, Llombart V, García-Berrocoso T, Inzitari D, Montaner J.

Biomarkers. 2017 May - Jun;22(3-4):200-209. doi: 10.1080/1354750X.2017.1286689. Epub 2017 Feb 14. Review.

PMID:
28117601
12.

Diagnosis, prognosis, and management of cryptogenic stroke.

Zhang C, Kasner S.

F1000Res. 2016 Feb 12;5. pii: F1000 Faculty Rev-168. doi: 10.12688/f1000research.7384.1. eCollection 2016. Review.

13.

Cryptogenic Stroke And Role Of Loop Recorder.

PérezRodon J, FranciscoPascual J, RivasGándara N, RocaLuque I, Bellera N, MoyaMitjans À.

J Atr Fibrillation. 2014 Dec 31;7(4):1178. doi: 10.4022/jafib.1178. eCollection 2014 Dec. Review.

14.

Genetics of stroke.

Guo JM, Liu AJ, Su DF.

Acta Pharmacol Sin. 2010 Sep;31(9):1055-64. doi: 10.1038/aps.2010.141. Epub 2010 Aug 23. Review.

15.

Gene expression profiling in stroke: relevance of blood-brain interaction.

Asano S, Chantler PD, Barr TL.

Curr Opin Pharmacol. 2016 Feb;26:80-6. doi: 10.1016/j.coph.2015.10.004. Epub 2015 Nov 9. Review.

Supplemental Content

Support Center